These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26226849)

  • 41. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic cannabinoids: analysis and metabolites.
    Elsohly MA; Gul W; Wanas AS; Radwan MM
    Life Sci; 2014 Feb; 97(1):78-90. PubMed ID: 24412391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A structure-reactivity relationship driven approach to the identification of a color test protocol for the presumptive indication of synthetic cannabimimetic drugs of abuse.
    Isaacs RCA
    Forensic Sci Int; 2014 Sep; 242():135-141. PubMed ID: 25062530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8.
    Koller VJ; Auwärter V; Grummt T; Moosmann B; Mišík M; Knasmüller S
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):164-71. PubMed ID: 24686252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana.
    Lauritsen KJ; Rosenberg H
    Am J Drug Alcohol Abuse; 2016 Jul; 42(4):377-84. PubMed ID: 26910181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
    Yanes EG; Lovett DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DART-MS as a preliminary screening method for "herbal incense": chemical analysis of synthetic cannabinoids.
    Lesiak AD; Musah RA; Domin MA; Shepard JR
    J Forensic Sci; 2014 Mar; 59(2):337-43. PubMed ID: 24313746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.
    Wohlfarth A; Pang S; Zhu M; Gandhi AS; Scheidweiler KB; Liu HF; Huestis MA
    Clin Chem; 2013 Nov; 59(11):1638-48. PubMed ID: 24014837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
    Hutter M; Broecker S; Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
    de Castro A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M
    J Chromatogr A; 2013 Jun; 1295():99-106. PubMed ID: 23680386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
    Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
    Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spice: a never ending story?
    Lindigkeit R; Boehme A; Eiserloh I; Luebbecke M; Wiggermann M; Ernst L; Beuerle T
    Forensic Sci Int; 2009 Oct; 191(1-3):58-63. PubMed ID: 19589652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gas Chromatography-Fourier Transform Infrared Spectroscopy for Unambiguous Determination of Illicit Drugs: A Proof of Concept.
    Salerno TMG; Donato P; Frison G; Zamengo L; Mondello L
    Front Chem; 2020; 8():624. PubMed ID: 32850646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').
    Curtis B; Alanis-Hirsch K; Kaynak Ö; Cacciola J; Meyers K; McLellan AT
    Drug Alcohol Rev; 2015 Jan; 34(1):105-8. PubMed ID: 25196534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The illegal synthetic cannabinoid drug market in Israel - evolution and new challenges].
    Shapira B; Poperno A; Berkovitz R
    Harefuah; 2016 Sep; 155(9):526-530. PubMed ID: 28530077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.
    Castellanos D; Gralnik LM
    World J Clin Pediatr; 2016 Feb; 5(1):16-24. PubMed ID: 26862498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice.
    Lefever TW; Marusich JA; Thomas BF; Barrus DG; Peiper NC; Kevin RC; Wiley JL
    Subst Abuse; 2017; 11():1178221817701739. PubMed ID: 28469427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic Cannabinoid 'Bonzai' Intoxication: Six Case Series.
    Ergül DF; Ekemen S; Yelken BB
    Turk J Anaesthesiol Reanim; 2015 Oct; 43(5):347-51. PubMed ID: 27366526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacological properties of law-evading chemical substances].
    Funada M
    Nihon Rinsho; 2015 Sep; 73(9):1487-90. PubMed ID: 26394508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.